Cytek BioSciences Current Cash

Cytek BioSciences (CTKB) currently reports a current cash of $66M as of March 2026. That compares with $95M in the prior-year period — down 31.1% year over year. Use the charts on this page to explore Cytek BioSciences's current cash history and peer comparisons.

Cytek BioSciences's current cash decreased from $95M to $66M — a 31.1% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Cytek BioSciences reported $66M in current cash as of March 2026. That compares with $95M in the prior-year period — down 31.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $66M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Cytek BioSciences, and consider following CTKB for alerts when major investors trade the stock.

Cytek BioSciences is classified in the Healthcare sector. On current cash, it currently shows $66M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CTKB with unrelated industries.